Combination Radiation with Immunotherapy Shows Promise Against Cold Breast Cancer Tumors
Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models of triple negative breast cancer, a cancer type that’s typically resistant to immunotherapy alone.
National Organization for Rare Disorders Designates WCM and NYPWCMC as a Rare Disease Center of Excellence
Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center have together been named a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD).
WCM and NYP Receive NIH Support for Project Addressing Postpartum Maternal Health in Underserved Communities
As part of a National Institutes of Health initiative to improve maternal health and pregnancy outcomes nationwide, Weill Cornell Medicine and NewYork-Presbyterian will play a pivotal role as collaborators with Columbia University Irving Medical Center (CUIMC) as one of 10 nationwide IMPROVE (Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone) Maternal Health Research Centers of Excellence.
Dr. Arnar Geirsson Named Director Cardiovascular Institute and Surgical Heart Valve Program
Dr. Arnar Geirsson, a pioneer in minimally invasive and robotic cardiac surgical procedures, has been appointed director of the Cardiovascular Institute and Surgical Heart Valve Program at NewYork-Presbyterian and Columbia University Irving Medical Center, effective Sept. 1.
Catholic Health Collaborates with NYP to Expand Access to World-Class Heart Care
Catholic Health and NewYork-Presbyterian, two leading health care systems serving the New York metropolitan area, announced they have signed a clinical collaboration agreement to provide an unparalleled level of cardiac care in Long Island.
A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.
Physician Story: Gastroenterology
Dr. Bo Shen: A Career Dedicated to Transforming Care for Complex IBD and Ileal Pouch Disorders
Medical Director of Columbia’s Inflammatory Bowel Disease Center transforms the field of interventional IBD for the management of complex IBD and pouch disorders.
NYPH Named One of Nation’s Best Hospitals by US News World Report 20th Year in a Row
NewYork-Presbyterian Hospital has once again been recognized as one of the best hospitals in the nation and a top hospital in New York by U.S. News & World Report.
Page1 of 329